ask="3.6000"
ask_size="300"
average_daily_volume="127044"
bid="N/A"
bid_size="N/A"
book_value="1.4000"
change="+0.0801"
change_from_200_day_moving_average="1.5668"
change_from_50_day_moving_average="0.9570"
change_from_52_week_high="-2.0999"
change_From_52_week_low="2.0901"
change_in_percent="+3.1786%"
close="2.6001"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.3000"
ebitda="-2.11M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="2160000"
high="2.6400"
high_52_weeks="4.7000"
last_trade_date="3/10/2017"
last_trade_price="2.6001"
last_trade_size="332"
last_trade_time="3:56pm"
low="2.5000"
low_52_weeks="0.5100"
market_capitalization="6.97M"
moving_average_200_day="1.0333"
moving_average_50_day="1.6431"
name="XTL Biopharmaceuticals Ltd. - A"
notes="N/A"
one_year_target_price="30.0000"
open="2.5000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+151.6234%"
percent_change_from_50_day_moving_average="+58.2397%"
percent_change_from_52_week_high="-44.6787%"
percent_change_from_52_week_low="+409.8235%"
previous_close="2.5200"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.8000"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.3000"
stock_exchange="NCM"
symbol="XTLB"
volume="78304"
weeks_range_52="0.5100 - 4.7000"
